Cargando…
Chloroquine may induce endothelial injury through lysosomal dysfunction and oxidative stress
COVID-19 is a pandemic with no end in sight. There is only one approved antiviral agent but global stocks are deemed insufficient. Despite in vitro antiviral activity, clinical trials of chloroquine and hydroxychloroquine were disappointing, and they may even impair outcomes. Chloroquine causes zebr...
Autores principales: | Gregório, PauloC., da Cunha, Regiane S., Biagini, Gilson, Bosquetti, Bruna, Budag, Júlia, Ortiz, Alberto, Sánchez-Niño, Maria Dolores, Barreto, Fellype C., Stinghen, Andréa E.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826090/ https://www.ncbi.nlm.nih.gov/pubmed/33484708 http://dx.doi.org/10.1016/j.taap.2021.115412 |
Ejemplares similares
-
In vitro anti-inflammatory effects of vitamin D supplementation may be blurred in hemodialysis patients
por: Gregório, Paulo C., et al.
Publicado: (2021) -
Sevelamer reduces endothelial inflammatory response to advanced glycation end products
por: Gregório, Paulo C, et al.
Publicado: (2018) -
How do Uremic Toxins Affect the Endothelium?
por: da Cunha, Regiane Stafim, et al.
Publicado: (2020) -
Endothelial Microparticles in Uremia: Biomarkers and Potential Therapeutic Targets
por: Favretto, Giane, et al.
Publicado: (2019) -
Vitamin D and chronic kidney disease: an uneasy relationship
por: Barreto, Fellype Carvalho, et al.
Publicado: (2020)